Find your Advisor
back
Date
18. June 2019
Category
Deal Brief

Deal Announcement Industrials - Lixis

IMAP advises pharma quality control company Lixis on cross-border sale to SEA Vision. Pharmaceutical quality control company Lixis, to SEA Vision, a global leader in pharmaceutical inspection systems. Terms of the transaction were not disclosed. 

SEA Vision is an Italian company specializing in vision and track-andtrace systems for the pharmaceutical industry, with a consolidated turnover of €60 million. Lixis is an Argentinian company with over 17 years of experience in pharmaceutical vision, control and track-andtrace systems. 

The operational synergies between the companies will enable SEA Vision to become the leading group providing both software and hardware in its target market in Latin America, with a local workforce of 70 professionals. Lixis has already been collaborating with SEA Vision in the Brazilian market through the São Paulo-based subsidiary SEA Vision Latin America (SVLA).

IMAP Argentina, led by Pablo Teubal and Pedro Querio, acted as exclusive financial advisor to Lixis.

Key contacts

Pablo Teubal

Partner
Pedro Querio

Partner

Latest dealbriefs

Contact us
CONNECT WITH AN ADVISOR.
Middle-market M&A is a world of opportunity, and with that comes a sea of options and moving parts. Your advisor is the compass. Contact us for a no-commitment consultation with an M&A specialist, who’ll listen carefully to your concerns and give an honest, unbiased assessment on the best way forward.
Our business is your business growth
more information? 

Contact us 

We love to hear from you. Our team is always here to chat.

Contact form 

Thank you for your interest in IMAP. Please use the form below to tell us more about your current situation and we’ll be sure to have the right professional get back to you as soon as possible.